SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001370368-24-000017
Filing Date
2024-04-23
Accepted
2024-04-23 06:06:36
Documents
6
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 6-K a240423-6k.htm 6-K 15718
2 99.1 FINANCIAL REPORT Q1 2024 a240423-99_1.htm EX-99 200350
3 99.2 INTERIM FINANCIAL REPORT a240423-99_2.htm EX-99 936414
4 IMAGE letterheadpr.jpg GRAPHIC 25357
5 IMAGE logorm.jpg GRAPHIC 29788
6 IMAGE coverifr.jpg GRAPHIC 118317
  Complete submission text file 0001370368-24-000017.txt   1380873
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-15024 | Film No.: 24862607
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)